TipRanks
Go Ultimate75% OFF

James Vincent Insider Profile

4 Followers

James Vincent, Director at Alnylam Pharma, holds 0.00 shares in Alnylam Pharma (Ticker: ALNY). Most recently, James Vincent Sold 22,100 shares of Alnylam Pharma on Jun 18, 2010 for an estimated value of $336.12K.

James Vincent's Trading History

ALNY
Alnylam Pharma
Jun 18, 2010DirectorInformative Sell336.12K$0.00
ALNY
Insider Shares: 0.00 (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 18, 2010Informative Sell$336.12K22,100$15.20+39.40%
Jun 17, 2010Informative Sell$480.00K30,000$16.00+42.10%
Jun 15, 2010Informative Sell$527.14K32,900$16.02+42.70%

You May Also Like

James Vincent insider profile FAQ

What is the percentage of profitable transactions made by James Vincent?
The percentage of profitable transactions made by James Vincent is 100%.
What is the average return per transaction made by James Vincent?
The average return per transaction made by James Vincent is 41.40%.
What stocks does James Vincent hold?
James Vincent holds: ALNY stocks.
What was James Vincent’s latest transaction?
James Vincent’s latest transaction was an Informative Sell of $336.12K.
What was James Vincent's most profitable transaction?
James Vincent’s most profitable transaction was an Informative Sell of ALNY stock on June 15, 2010. The return on the trade was 42.70%.
What is James Vincent's role in Alnylam Pharma?
James Vincent's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.